Rare diseases
Investigational molecules
Locations
890 Winter Street, 02451-1470, United States
Kailera Therapeutics Inc. focuses on clinical research in obesity and overweight, with studies centered on changes in body weight and related metabolic outcomes.
Its research activity also includes participants with weight-related comorbidities and broader cardiometabolic risk profiles.
Kailera Therapeutics Inc. runs clinical trials in conditions such as Obesity, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
KAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaStudy of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
BulgariaComparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
